Your session is about to expire
← Back to Search
Oxygen Carrier
Hemopure for Anemia
N/A
Waitlist Available
Led By Carmine Gianatiempo, MD
Research Sponsored by Englewood Hospital and Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week
Awards & highlights
No Placebo-Only Group
Summary
This trial will allow people with life-threatening anemia to be treated with HBOC-201, which is not FDA approved in the US, but is approved as an oxygen carrier in South Africa and Russia.
Eligible Conditions
- Anemia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 week
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
survival
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: All subjectsExperimental Treatment1 Intervention
all qualifying subjects will receive HBOC-201 (Hemopure) to treat their life-threatening anemia
Find a Location
Who is running the clinical trial?
Englewood Hospital and Medical CenterLead Sponsor
20 Previous Clinical Trials
723 Total Patients Enrolled
HbO2 Therapeutics LLCIndustry Sponsor
2 Previous Clinical Trials
2 Trials studying Anemia
Carmine Gianatiempo, MDPrincipal InvestigatorEnglewood Hospital and Medical Center
1 Previous Clinical Trials
19 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You need to receive blood transfusions.You are allergic to beef products.
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.